Global Plant-based Vaccines Market to Surpass US$ 584.1 Million by 2028, Says Coherent Market Insights (CMI)

NEXT STORY
TRACON Pharmaceuticals Presents Data from a Phase 1 Study of Uliledlimab (TJ004309) and Tecentriq® (Atezolizumab) at the American Society of Clinical Oncology Virtual Annual Meeting
PREV STORY
Immunoassay Market Worth $46.5 Billion by 2028, Growing at a CAGR of 7.5% From 2021- Exclusive Report by Meticulous Research®
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study

Target Exceeded with More than 160 Patients Enrolled Top-Line Data on Track for 3Q17 ...

author_avatar
NASDAQ Market News

Checkmate Pharmaceuticals Announces Data Presentations for CMP-001 at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting

author_avatar
NASDAQ Market News

Immuron Reports Results in Severe Alcoholic Hepatitis Clinical Trial

author_avatar
NASDAQ Market News